Ferraro Lou 4
4 · SYNCHRONOSS TECHNOLOGIES INC · Filed Sep 13, 2024
Insider Transaction Report
Form 4
Ferraro Lou
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-09-12$13.61/sh−926$12,603→ 83,556 total - Exercise/Conversion
Common Stock
2024-09-12$9.90/sh+926$9,167→ 84,482 total - Exercise/Conversion
Common Stock
2024-09-12$10.71/sh+4,842$51,858→ 88,398 total - Sale
Common Stock
2024-09-12$13.60/sh−4,842$65,851→ 83,556 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-12$10.71/sh−4,842$51,858→ 0 totalExercise: $10.71From: 2023-07-08Exp: 2029-07-08→ Common Stock (4,842 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-12$9.90/sh−926$9,167→ 0 totalExercise: $9.90From: 2023-11-02Exp: 2029-11-02→ Common Stock (926 underlying)
Footnotes (2)
- [F1]Sales related to year-end tax planning.
- [F2]This grant has a graded vesting schedule, so date exercisable varies for each vesting tranche - 2,421 shares became exercisable on July 8, 2023 and 2,421 shares became exercisable on April 26, 2024.